Kunnen vitamines het ontstaan van Alzheimer
  uitstellen?*
Een artikel uit de Times online waaruit blijkt dat in het
  bijzonder B-vitamines  en
  foliumzuur dit inderdaad kunnen doen.
When John
  Roberts’s wife was found to have Alzheimer’s disease five years ago, at
  the age of 74, what amazed him was how little the doctors had to offer. “The
  psychiatrist said that he was sorry and that I was going to have a problem,”
  said Roberts, a county councillor in Wales. “‘Keep her happy,’ he said,
  and that was all.” 
This
  prescription may sound inadequate in the face of a disease that may involve
  not only a progressive memory loss but also confusion, depression, fits of
  anger and the disintegration of personality. Conventional medicine can still
  do little more than help with symptoms but in fact there is another approach,
  as Roberts discovered, which sounds absurdly simple — take vitamins and
  mineral supplements. 
Almost
  unnoticed by mainstream medicine, the evidence has been piling up over the
  past few years that there is a strong link between the amount of an amino acid
  called homocysteine in your blood and your chance of developing Alzheimer’s.
  Apparently you can lower the level, along with your risk of contracting the
  disease, simply by taking a combination of B vitamins, antioxidants and
  minerals. 
“Keeping
  your homocysteine level low halves your risk of developing Alzheimer’s,”
  says Teodoro Bottiglieri, a neuropharmacologist at the Baylor Institute of
  Metabolic Disease in Dallas, Texas. Professor Bottiglieri is one of the
  speakers at a conference taking place in London tomorrow and Monday (February
  1 and 2) devoted to the emerging discipline of nutritional psychiatry. 
Besides
  discussing Alzheimer’s, researchers will also be talking about
  schizophrenia, depression and eating disorders. 
Much
  of this research has been done in the face of official indifference and one of
  the most dogged researchers on the homocysteine trail is another speaker, the
  Welsh GP Andrew McCaddon. Running small studies from the University of Wales,
  he’s been piecing the story together for the past decade. Several years ago
  he showed that patients with Alzheimer’s have significantly raised levels of
  homocysteine. Next he reported that the more homocysteine they had, the worse
  their mental performance and then last year he reported that the worse their
  “cognitive impairment” the less they had of an antioxidant called
  glutathione. 
That
  finding looks particularly interesting in light of a report that came out only
  this week from the Johns Hopkins Bloomberg School of Public Health in
  Baltimore. It described a five-year study, involving 4,740 people over 65,
  which found that those taking large doses of the antioxidant vitamins C and E
  had between a 64 per cent and 78 per cent lower risk of developing the
  disorder. 
So
  what is going on here? Conventionally, Alzheimer’s has been seen to involve
  a rogue protein known as beta-amyloid that forms the deadly plaques and
  “tangles” that destroy brain cells. What have B vitamins and antioxidants
  to do with that? “In fact what is extraordinary is that B vitamins have been
  excluded from the Alzheimer picture for so long,” says Bottiglieri. 
“The
  link between brain deterioration — memory loss, cognitive deficits,
  depression, and personality breakdown — and B vitamin deficiency is standard
  neurology text-book stuff. You get it with severe alcoholism, with some
  genetic disorders that prevent B vitamins functioning properly and with
  pernicious anaemia. The trouble is that there is a lot of money tied up in the
  amyloid protein story.” 
What
  has changed matters is the development of a simple blood test to detect
  homocysteine levels, so it can be used to check how well your B vitamins are
  working. That’s because the body needs B vitamins to handle homocysteine,
  which it normally turns into two very useful chemicals called glutathione and
  the amino acid SAMe. This, in turn, is vital for manufacture of one of the
  main neurotransmitters, acetylcholine. Alzheimer’s patients have very low
  levels of SAMe Acetylcholine should ring bells because not only is it
  essential for laying down memories, but it is almost always found at very low
  levels in Alzheimer patients. In fact, when patients do get drugs they are
  usually aimed at boosting acetylcholine levels by preventing it from being
  broken down. Their drawback is that the drugs only slow the decline slightly
  and can cause liver damage, nausea and vomiting. 
On
  the other hand, getting the homocysteine-to-acetylcholine pathway working
  properly by adding B vitamins doesn’t seem to lead to these problems. 
But
  why do the antioxidants, such as vitamin C and E, make a difference? “One of
  the effects of the amyloid plaques encroaching on the brain is a rise in the
  production of free radicals, or oxidative stress,” explains McCaddon.
  “This adds to the problem because they reduce the effectiveness of the B
  vitamins in transforming homocysteine.” Antioxidants, such as vitamin C and
  E “mop up” the damaging free radicals. It is detailed molecular-level
  research such as this that is encouraging scientists to take the
  vitamin-homocysteine-Alzheimer’s link seriously. 
“We
  have been giving people different vitamin levels and then taking blood and
  spinal fluid to see what effects they have,” says Bottiglieri. “We even
  have a mouse model that is genetically engineered to develop plaques and
  tangles. We’ve found that if you feed it on a diet low in B vitamins, the
  plaque becomes much more toxic and that the production of free radicals
  increases.” 
So
  what does all this mean in practical terms? “What would be really useful is
  if GPs stopped thinking about B vitamin deficiency in terms of anaemia,”
  says McCaddon. “Problems with the pathway involved with homocysteine often
  don’t show up as a deficiency. If they would measure homocysteine first and
  then take steps to lower it that would make a big difference.” 
Already
  the American Psychiatric Association recommends vitamin E supplements for
  Alzheimer’s patients but all the experts emphasise that there is still much
  work needed to fill in all the details of the new picture. “We know that
  raised homocysteine predicts cognitive decline,” says McCaddon. “What is
  still lacking is evidence from trials that lowering it makes a difference.
  It’ s reasonable to suppose it does, but we have to wait for the results of
  a big trial under way in the States due out next year.” 
Meanwhile
  given that extra vitamins are unlikely to do harm, finding out your
  homocysteine level would make sense. This is not a cure but it may well cut
  your risk and it looks like a promising way to help with symptoms. 
'I've
  got my wife back'
  
John
  Roberts first realised his wife’s increasing forgetfulness was a sign of
  something more serious about five years ago when she went shopping and
  couldn’t find her way home. 
For
  three years he watched helplessly as she gradually worsened. “She became
  very confused. She thought I was a stranger and she’d always been calm but
  now she was often angry and upset.” 
He
  became a member of the local Alzheimer’s society. “From what I saw of how
  the other patients progressed, I knew it wasn’t long before she would have
  to go into a home.” But then he went to see 
Dr
  Andrew McCaddon. “His approach was different from the psychiatrist. He did
  some blood tests and then put her on folic acid (a B vitamin) and other
  vitamins. 
It took a while,
  but within about six months there was a great improvement. She became calmer
  and started sleeping properly. When we went out, she noticed where she was
  going. Her recent memory is still not good but her underlying personality is
  there again. We can sit and have tea and biscuits, watch TV and talk. I’ve
  got my wife back.”